v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue $ 4,363,752 $ 4,957,489 $ 8,500,072 $ 9,575,030
Cost of goods sold 3,998,213 4,472,911 7,740,789 8,965,396
Gross Profit 365,539 484,578 759,283 609,634
Operating Expenses:        
Selling expenses 835,836 812,568 1,816,510 1,530,584
General and administrative expenses 1,589,775 1,539,323 3,003,920 2,901,569
Research and development expenses 271,745 242,556 547,879 472,679
Total Operating Expenses 2,697,356 2,594,447 5,368,309 4,904,832
Loss from Operations (2,331,817) (2,109,869) (4,609,026) (4,295,198)
Other Income (Expense):        
Interest and other income 22,378 64,605 39,235 133,356
Interest and other expense (231,160) (63,466) (440,224) (111,749)
Amortization of debt discount (401,951) (84,318) (489,455) (252,348)
Gain (loss) on foreign currency transactions (94,457) 34,060 (263,013) 69,576
Gain (loss) on disposal of property and equipment (15,058) (2,158) (15,058) (63,464)
Total Other Expense (720,248) (51,277) (1,168,515) (224,629)
Loss Before Income Taxes (3,052,065) (2,161,146) (5,777,541) (4,519,827)
Income tax benefit (370) (360) (747) (699)
Net Loss (3,051,695) (2,160,786) (5,776,794) (4,519,128)
Net Loss attributable to noncontrolling interest (35,330) (8,901) (50,317) (15,851)
Net Loss attributable to LiqTech International, Inc. $ (3,016,365) $ (2,151,885) $ (5,726,477) $ (4,503,277)
Loss Per Common Share – Basic and Diluted (in dollars per share) $ (0.14) $ (0.14) $ (0.32) $ (0.3)
Weighted-Average Common Shares Outstanding – Basic and Diluted (in shares) 20,808,160 14,906,781 18,033,180 14,906,781